IMARC Group’s report titled “Apheresis Market Report by Component (Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or Leukopheresis), Lymphocytes (Lymphopheresis or Lymphapheresis), RBC's (Erythropheresis)), Product (Devices, Disposables and Reagents, Software), Technology (Centrifugation, Membrane Separation, Selective Adsorption), Procedure (Donor/Automated Apheresis, Therapeutic Apheresis), Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Others), End User (Blood Centers, Hospitals, and Others), and Region 2024-2032”. The global apheresis market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.59% during 2024-2032.

Factors Affecting the Growth of the Apheresis Industry:

• Increasing Prevalence of Chronic Diseases:

Chronic diseases like cancer, autoimmune disorders, and blood conditions often need treatments that remove harmful blood components. Apheresis procedures can do this, helping to manage symptoms and slow disease progression. Additionally, apheresis techniques are useful for diagnosing various chronic diseases. They aid in analyzing blood components and identifying biomarkers, thus supporting disease diagnosis and monitoring.

• Technological Advancements:

Recent innovations in apheresis technology have made blood component separation more efficient. These advancements lead to faster procedures and higher collection rates. Modern machines now feature advanced automation for precise control. This ensures accurate separation of blood components, reducing errors and improving patient outcomes.

• Growing Demand for Blood Components:

Apheresis procedures collect specific blood components like platelets, plasma, and white blood cells. These are used in transfusion medicine, hematology, oncology, and immunology. Platelets, vital for stopping bleeding, are crucial for patients with bleeding disorders, those undergoing surgery, or receiving chemotherapy. Apheresis efficiently gathers platelets from one donor, meeting the high demand for them.

Request for a sample copy of this report: https://www.imarcgroup.com/apheresis-market/requestsample

Leading Companies Operating in the Global Apheresis Industry:

• Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)
• B. Braun SE
• Charles River Laboratories International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Haemonetics Corporation
• Haier Biomedical
• Kaneka Corporation
• Medica S.p.a.
• Miltenyi Biotec
• Nikkiso Co. Ltd.
• Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited)
• Terumo Bct Inc. (Terumo Corporation).

Apheresis Market Report Segmentation:

By Component:

• Plasma (Plasmapheresis)
• Platelets (Plateletpheresis)
• Leukocytes (Leukapheresis or Leukopheresis)
• Lymphocytes (Lymphopheresis or Lymphapheresis)
• RBC's (Erythropheresis)

Plasma (Plasmapheresis) represents the largest segment due to the increasing demand for plasma-derived medications and therapeutic applications in treating a wide range of medical conditions.

By Product:

• Devices
• Disposables and Reagents
• Software

Disposables and reagents account for the majority of the market share owing to their essential role in apheresis procedures, requiring frequent replenishment.

By Technology:

• Centrifugation
• Membrane Separation
• Selective Adsorption

Centrifugation exhibits a clear dominance in the market driven by its widespread adoption, efficiency in separating blood components, and versatility in accommodating various apheresis procedures.

By Procedure:

• Donor/Automated Apheresis
• Therapeutic Apheresis

Donor/automated apheresis holds the biggest market share on account of its efficiency, convenience, and ability to collect specific blood components from donors for therapeutic and transfusion purposes.

By Application:

• Renal Disorders
• Hematological Disorders
• Neurological Disorders
• Autoimmune Disorders
• Others

Hematological disorders hold the biggest market share as apheresis procedures play a critical role in the management and treatment of various hematologic disorders, including leukemia, lymphoma, and aplastic anemia.

By End User:

• Blood Centers
• Hospitals
• Others

Blood centers represent the largest segment. They serve as key facilities for blood collection, processing, and distribution, playing a central role in meeting the demand for blood components derived from apheresis procedures.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position in the apheresis market, which can be attributed to its well-established healthcare infrastructure, high prevalence of chronic diseases, strong regulatory framework, and extensive adoption of advanced medical technologies.

Global Apheresis Market Trends:

There's a rising focus on personalized medicine, needing custom blood therapies from apheresis. Apheresis is now used more widely, treating neurological disorders, aiding transplants, and tackling immune diseases. This shift is broadening the market. Moreover, as awareness of apheresis benefits grows among doctors and patients, its use increases, boosting market growth.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145